China will reopen borders by the end of 2021 疫苗接种率需达到这个标准可以完全开放！

China will reopen borders by the end of 2021

China can completely open its borders when the vaccination rate reaches at least 80 percent by the end of the year, says China's top respiratory expert Zhong Nanshan.
When the rate exceeds 80 percent, Zhong said, it will effectively prevent Covid from spreading, and especially prevent severe illness, and most infected patients would have no symptoms or just suffer mild symptoms. He said he expects the rate to reach 80 percent by year-end.

Vaccination also effectively drops fatality rate of the disease, which is 1-2 percent worldwide, dozens of times of flu. When fatality rate is low enough, absolute most people who get COVID-19 will recover rather than one or two in every hundred could die, Zhong said. 

Zhong estimated the COVID-19 will slowly go through the process of dropping fatality rate and low infection rate, and low fatality rate and high vaccination rate is the threshold for opening up. 

China’s vaccination rate will reach 80 percent by year’s end, and the question to be address is how to maintain an effective protection rate which naturally declines after half a year. “That is what we are doing now -- to develop more vaccines and to research on how to boost immunity,” Zhong said. 

何时中国可以完全开放疫苗接种率需达到这个标准！
目前福建黑龙江疫情仍在持续，虽然疫情已经得到有效控制，多轮的疫情反弹不禁令人对开放时间进行猜测，究竟何时才能恢复到疫情前？来看看钟南山院士怎么说！
钟南山院士在接受专访时表示，什么时候中国完全可以开放？绝大多数人打了疫苗——起码80%甚至85%以上。接种疫苗后，对疾病的预防特别是预防（病情）加重的能力（变强），也就是说，我们多数人就无感或者只是很轻的感觉，这是一个（标准）。
钟南山估计，我们到2021年底（疫苗接种率）就在80%以上了，但接种疫苗后，一般来说不管国内国外，在半年以后预防效率会明显下降。所以我们在研发更多疫苗，以及（研究）怎么加强免疫来解决这个问题。

China's Sinovac approved by Australia 

Australia recognized China’s Sinovac Biotech Ltd. Covid-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.

The nation’s top drugs regulator, the Therapeutic Goods Administration, said the shots should be “recognized vaccines” in determining incoming travelers as being inoculated, Prime Minister Scott Morrison said Friday.

Australia is starting to unwind some of the world’s most intense pandemic border restrictions as vaccination rates across the country approach as key threshold of 80%. Recognition of Beijing-based Sinovac’s shot, which has been approved by the World Health Organization for emergency use, contrasts with the U.K. and neighboring New Zealand, which are yet to endorse it. 

A number of European countries have said they will accept the vaccine, known as Coronavac, as part of programs for vaccinated entry. 

Friday’s announcement potentially opens the door to thousands of foreign students that have been shut out of Australia during the pandemic. 

Vaccines made by Sinovac and the state-owned Sinopharm are among the most used in China, and have efficacy rates ranging from around 50% to 80% in preventing symptomatic Covid, lower than the mRNA vaccines developed out of the U.S. Sinovac is also one of the most-deployed Covid shots globally, used from Indonesia to Brazil and Turkey. Chile said earlier this week it would start administering it to children age six to 11. 
澳大利亚承认中国科兴
澳大利亚药品管理局（TGA）宣布承认中国科兴疫苗和印度Covishield新冠疫苗，为已经接种这些疫苗的人士入境澳大利亚铺平道路。
澳大利亚总理办公室网站1日发布的新闻稿指出，TGA当天公布了对科兴Coronavac疫苗和印度Covishield疫苗（由阿斯利康和印度血清研究所合作生产）提供的保护数据的初步评估，并建议将这两种疫苗列为“被承认的疫苗（recognised vaccines）”。
新闻稿称，宣布某一新冠疫苗为“被承认的疫苗”，与是否批准其在澳大利亚用于疫苗接种的监管决定是分开的。TGA尚未批准在澳境内接种上述两种疫苗。
目前，TGA批准在澳大利亚使用的疫苗，包括辉瑞/BioNTech疫苗（Comirnaty）、阿斯利康疫苗（Vaxzevria）、莫德纳疫苗（Spikevax）以及强生公司旗下的杨森疫苗。
不过新闻稿也称，承认这两种疫苗具有“里程碑意义”，这使得更多在澳大利亚境外接种这些疫苗的澳大利亚公民能够尽快回国。
据澳大利亚广播公司报道，TGA在最新一份声明中指出，该机构本次评估了6种疫苗，它们在中国、印度等亚太国家中被广泛使用，而澳大利亚通常接收的国际入境人员中有许多来自这些国家。
澳大利亚计划于11月开放国际边境，目前该国首剂疫苗接种率接近80%，有55%的民众已接种两剂疫苗。
莫里森1日表示，所有接种完两剂新冠疫苗的澳大利亚公民和永久居民将被允许在返澳后采取为期7天的居家隔离，而没有接种新冠疫苗的民众仍须在政府批准的定点设施，采取为期14天的酒店隔离。
值得一提的是，上个月，科兴和国药等中国疫苗获得了美国的“默认”。

China to ban core industrial and information data from leaving the country

Chinese authorities published data security draft regulations on Thursday that would ban the export of what was classified as core data, a step experts hail as a necessary step to ensure national security and normal functioning of society.
The draft regulations, published by China's Ministry of Industry and Information Technology (MIIT), classify data into three categories and ban the exports of what has been classified as core data.

According to the draft regulations, data generated from industrial and information technology sectors in China, including raw materials, equipment manufacturing consumer products, electronics manufacturing, explosives for civil uses and software, are subject to newly proposed restrictions. 

The government will classify data into three categories, with general data which has limited social impacts, vital data that could threaten China's economic, social, cultural, cyber, ecological and nuclear wellbeing and compromise China's overseas interests, and core data that seriously threatens national security and could have major social and economic implications. 

Data on biological, space, polar and deep-sea activity and artificial intelligence is considered to be vital or core data, depending on a data set's specific impacts. 

The draft regulations require all the data from industrial and information technology sectors to be stored within China according to relevant laws and regulations, and ban core data from leaving the country. They require security appraisals to be taken first for the exports of vital data if there is a compelling reason to be transferred outside of China. 

Analysts noted that Chinese companies overseas are also required to follow data security rules of the country of their operation. 

更多精彩，请访问我们的网站www.businesstianjin.com或关注我们的微信公众号：business_tianjin

2021 LATEST EDITIONS

2021 LATEST EDITIONS

Editor's Picks